Dexmedetomidine Sedation With Third Molar Surgery

Ketamine

Brief Summary

Intravenous sedation is used frequently for the relief of pain and anxiety associated with oral surgical procedures performed under local anesthesia. The purpose of this study is to learn about patient and surgeon satisfaction with sedation using Dexmedetomidine in combination with midazolam alone or with midazolam plus low dose ketamine while having wisdom teeth removed. The sedation produced by dexmedetomidine is unique in that it mimics natural sleep, a unique quality not shared by other drugs. Dexmedetomidine is often used in anesthesia in hospital operating rooms and has been approved by the US Food and Drug Administration for the use planned in this study.

Intervention / Treatment

  • Dexmedetomidine (DRUG)
    Dexmedetomidine will be infused at a rate of 6 mcg/kg/hr for four minutes; resulting in a loading dose of 0.4 mcg/kg, Followed by an infusion of 0.5 mcg/kg/hr will be initiated and continued until the completion of surgery.
  • Midazolam (DRUG)
    Midazolam 0.04 mg/kg i.v. administered after dexmedetomidine loading dose.
  • Ketamine (DRUG)
    Ketamine 0.25 mg/ml administered i.v. following the dexmedetomidine loading dose and the midazolam.

Condition or Disease

  • Anesthesia

Phase

  • Phase 4

    • Study Design

    Study type: INTERVENTIONAL
    Status: Terminated
    Study results: No Results Available
    Age: 18 Years to 30 Years
    Enrollment: 18 (ACTUAL)
    Funded by: Other
    Allocation: Randomized
    Primary Purpose: Treatment

    Masking

    QUADRUPLE:
    • Participant
    • Care Provider
    • Investigator
    • Outcomes Assessor

    Clinical Trial Dates

    Start date: Jul 01, 2009
    Primary Completion: Dec 01, 2011 ACTUAL
    Completion Date: Dec 01, 2011 ACTUAL
    Study First Posted: Nov 20, 2009 ESTIMATED
    Results First Posted: Jun 17, 2013 ESTIMATED
    Last Updated: May 07, 2013

    Sponsors / Collaborators

    Lead Sponsor: N/A
    Lead sponsor is responsible party
    Responsible Party: N/A

    Location

    Chapel Hill, North Carolina, USA

    Subjects who have been screened medically and are scheduled for third molar surgery in the University of North Carolina (UNC)Oral and Maxillofacial Surgery (OMFS) clinic will be asked to volunteer for the study by the evaluating OMFS resident or attending physician. No additional x-rays will be taken other than those usually indicated for 3rd molar surgery. Informed consent will be obtained by study investigators.

    Subjects will be instructed to fast for at least 8 hours prior to their appointment. Surgery will be performed in the Oral \& Maxillofacial Surgery operating/sedation clinic where all monitoring equipment as well as emergency equipment is readily available, including the ability to ventilate the patient with oxygen (bag-mask), the ability to intubate, resuscitation drugs and equipment including a defibrillator. Patients will be positioned in a semi-reclining position in the dental chair and all monitors applied. A 20 gauge i.v. catheter will be placed and normal saline infusion attached. Supplemental oxygen will be administered via nasal cannula at 3 liters per minute. A picture will then be shown for recall testing. Pulse rate, arterial oxygen saturation (SpO2), respiratory rate, blood pressure, end-tidal CO2 (ETCO2), Ramsey Sedation Score (RSS sedation score) and Bispectral Index Scale (BIS) value will be recorded as a baseline and at 5 minute intervals during the procedure. Any SpO2 values below 90% as well as any episodes of apnea greater than 20 seconds will be recorded. Monitoring and recording of all data will be done by one of the investigators. Data will be recorded on pre-printed data forms. The surgical procedure will be performed by an oral and maxillofacial surgery resident physician.

    Following the administration of 0.12 mg/kg of dexamethasone , dexmedetomidine will be infused at a rate of 6 mcg/kg/hr for four minutes; resulting in a loading dose of 0.4 mcg/kg. All of the above parameters will again be obtained and recorded. Patients will be randomly assigned by block randomization to receive either midazolam 0.04 mg/kg i.v. (50 patients), or midazolam 0.04 mg/kg plus 0.25 mg/kg of ketamine (50 patients). The operating surgeon and the patient will be blinded as to which protocol is being used. A dexmedetomidine infusion of 0.5 mcg/kg/hr will be initiated and continued until the completion of surgery. At this point local anesthesia will be administered in all four quadrants. Pain reaction during injections will be recorded. When efficacy of local anesthesia has been confirmed, surgery will commence. The surgery will be interrupted at 15 and 30 minutes to show a picture for recall testing by an investigator. If at any point the patient is deemed to be uncomfortable or uncooperative due to inadequate sedation, the protocol will be broken and additional sedation administered as per usual standards. The rescue therapy may include additional midazolam, ketamine, narcotic or propofol at the discretion of the anesthetist/sedationist. At the conclusion of surgery the dexmedetomidine infusion will be discontinued and the patient will be attended by a recovery nurse for collection of postoperative data. During recovery the physiologic parameters will be recorded at 10 minute intervals. When the patient achieves a recovery Aldrete score of \>9, they will be asked by an investigator to recall pictures for amnesia assessment, and asked to assess patient satisfaction before leaving with an escort. The patient will be contacted on the day following surgery by phone or e-mail by one of the investigators to test for recall of pictures shown (amnesia testing) and patient satisfaction

    Participant Groups

    • Dexmedetomidine loading dose of 0.4 mcg/kg followed by an infusion of 0.5 mcg/kg/hr plus midazolam 0.04 mg/kg i.v.

    • Dexmedetomidine loading dose of 0.4 mcg/kg followed by an infusion of 0.5 mcg/kg/hr plus midazolam 0.04 mg/kg and 0.25 mg/kg ketamine i.v.

    Eligibility Criteria

    Sex: All
    Minimum Age: 18
    Maximum Age: 30
    Age Groups: Adult
    Healthy Volunteers: Yes

    Inclusion Criteria:

    * American Society of Anesthesiology (ASA) physical status I and II
    * Four asymptomatic third molars indicated for removal

    Exclusion Criteria:

    * Clinical history or ECG evidence of:

    * cardiac dysrhythmia or heart block
    * ischemic heart disease
    * asthma
    * sleep apnea
    * impaired liver, renal, or mental function
    * chronic sedative or analgesic use
    * allergies to any of the study drugs
    * history of pericoronal infection with third molars

    Primary Outcomes

    • Subjects were shown pictures of familiar objects prior to sedation, after the bolus dose of dexmedetomidine was administered, at 15 minutes and 30 minutes into the surgery and at the end of surgery. Subjects were shown a page containing multiple pictures to evaluate whether they could remember any of them. No recall demonstrating the presence of amnesia during that portion of the procedure. This process was repeated the day following surgery

    • Lack of recall of picture shown indicates presence of amnesia the day following surgery.

    • Percentage of patients unable to recall picture

    • Inability to recall picture shown at this time indicates presence of amnesia on the day following surgery.

    • Lack of recall of picture shown at this time indicates presence of amnesia

    • Lack of recall of picture demonstrates presence of amnesia on day following surgery

    • Lack of recall of picture shown indicates presence of amnesia

    • Lack of recall of picture shown indicates presence of amnesia on day following surgery.

    • Lack of recall of picture shown indicates presence of amnesia

    • Lack of recall of picture shown indicates presence of amnesia on day following surgery.

    Secondary Outcomes

    • Respirations per minute

    • Rate of respirations

    • Oxyhemoglobin saturation per pule oximeter

    • Oxyhemoglobin saturation per pulse oximetry

    • Measured via capnography at nares

    • Measured by capnography at nares

    • Blood pressure per automated monitor

    • Measured using automated blood pressure monitor

    • Heart rate per EKG monitor

    • Per EKG monitor

    • Numerical value on scale of 1-5 from Very dissatisfied (1) to Extremely satisfied (5)

    • Rating of how satisfied the patient was with their sedation on a scale of 1-5 with 1 being very dissatisfied and 5 being extremely satisfied

    • Rating of depth of sedation by sedationist. Scale 1 - 6, 1 being widw awake and 6 being non-responsive

    • Bispectral Index (BIS) measures level of consciousness by algorithmic analysis of the patient's electroencephalogram (EEG) during anesthesia and sedation. The BIS can range from 0 (equivalent to EEG silence) to 100 (equivalent to fully awake and alert). A BIS value of 40-60 indicates an adequate general anesthesia state.

    More Details

    NCT Number: NCT01017237
    Other IDs: 08-2157
    Study URL: https://clinicaltrials.gov/study/NCT01017237
    Last updated: Sep 29, 2023